Results
eNauka >
Rezultati >
Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2
| Naziv: | Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2 | Autori  : | Tiede, Andreas; Janic, Dragana M   ; Ozelo, M; Santagostino, E; Korsholm, Lars; Matytsina, Irina; Lentz, SR |
Godina: | 2018 | Publikacija: | Haemophilia. Special Issue: 11th Annual Congress of the European Association for Haemophilia and Allied Disorders 2018, 7–9 February 2018, Madrid, Spain February 2018 | ISSN: | 1351-8216 Haemophilia Pretraži identifikator |
Izdavač: | Wiley Online Library | Tip rezultata: | Konferencijski rad | Kolacija: | vol. 24 br. S1 str. 32-135 | DOI: | 10.1111/hae.13393 | WoS-ID: | 000423774100082 | URI: | https://enauka.gov.rs/handle/123456789/818452 | URL: | https://onlinelibrary.wiley.com/doi/epdf/10.1111/hae.13393 https://onlinelibrary.wiley.com/doi/10.1111/hae.13393 https://onlinelibrary.wiley.com/toc/13652516/2018/24/S1 |
Projekat: | Alnylam Baxter/Baxalta/Shire Bayer Biogen Idec Biotest CSL Behring Novo Nordisk A/S Octapharma Pfizer Roche Sobi Baxter Shire |
Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.